FDA Approved: VYXEOS — Original Application (Jazz Pharmaceuticals, Inc.)

View source ↗

Summary

FDA granted original approval for VYXEOS (daunorubicin and cytarabine liposome) for adults with therapy-related acute myeloid leukemia or acute myeloid leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia with Myelodysplasia-related Changes
• Therapy-related Acute Myeloid Leukemia

Drugs mentioned

• Vyxeos (CPX-351)

Snippet

ORIG AP for VYXEOS ((DAUNORUBICIN AND CYTARABINE) LIPOSOME)